These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 31898195

  • 1. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T.
    Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
    [Abstract] [Full Text] [Related]

  • 2. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Fukushima S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
    [Abstract] [Full Text] [Related]

  • 3. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
    Ono T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Akiyama T, Sugaya J, Fukushima S, Kojima N, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
    [Abstract] [Full Text] [Related]

  • 4. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2020 Jul; 33(3):877-885. PubMed ID: 32274656
    [Abstract] [Full Text] [Related]

  • 5. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines.
    Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T.
    Sci Rep; 2017 Jul 05; 7(1):4712. PubMed ID: 28680140
    [Abstract] [Full Text] [Related]

  • 6. Establishment and characterization of NCC-SS6-C1: a novel patient-derived cell line of synovial sarcoma.
    Osaki J, Noguchi R, Ono T, Adachi Y, Iwata S, Toda Y, Funada T, Iwata S, Kojima N, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2024 Nov 05; 37(6):1734-1741. PubMed ID: 39174825
    [Abstract] [Full Text] [Related]

  • 7. Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Sugaya J, Kojima N, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2022 Jul 05; 35(4):1290-1297. PubMed ID: 35655041
    [Abstract] [Full Text] [Related]

  • 8. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1.
    Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Nakagawa R, Kamio S, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2022 Jul 05; 35(4):1262-1269. PubMed ID: 35441357
    [Abstract] [Full Text] [Related]

  • 9. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
    Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sugaya J, Kobayashi E, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2022 Nov 05; 35(6):2011-2019. PubMed ID: 36103079
    [Abstract] [Full Text] [Related]

  • 10. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
    Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2019 Apr 05; 32(2):214-222. PubMed ID: 30737712
    [Abstract] [Full Text] [Related]

  • 11. Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs.
    Nakai S, Yamada S, Outani H, Nakai T, Yasuda N, Mae H, Imura Y, Wakamatsu T, Tamiya H, Tanaka T, Hamada K, Tani A, Myoui A, Araki N, Ueda T, Yoshikawa H, Takenaka S, Naka N.
    Sci Rep; 2019 Nov 01; 9(1):15812. PubMed ID: 31676869
    [Abstract] [Full Text] [Related]

  • 12. Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
    Carrabotta M, Laginestra MA, Durante G, Mancarella C, Landuzzi L, Parra A, Ruzzi F, Toracchio L, De Feo A, Giusti V, Pasello M, Righi A, Lollini PL, Palmerini E, Donati DM, Manara MC, Scotlandi K.
    Cancer Res; 2022 Feb 15; 82(4):708-720. PubMed ID: 34903601
    [Abstract] [Full Text] [Related]

  • 13. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.
    Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.
    In Vitro Cell Dev Biol Anim; 2019 Jan 15; 55(1):62-73. PubMed ID: 30411273
    [Abstract] [Full Text] [Related]

  • 14. Establishment and characterization of NCC-MFS3-C1: a novel patient-derived cell line of myxofibrosarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Sei A, Takeshita F, Sugaya J, Iwata S, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2021 Jul 15; 34(4):1266-1273. PubMed ID: 33990915
    [Abstract] [Full Text] [Related]

  • 15. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Ono T, Sei A, Takeshita F, Sugaya J, Iwata S, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2021 May 15; 34(3):998-1007. PubMed ID: 33611700
    [Abstract] [Full Text] [Related]

  • 16. Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Nakagawa M, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2020 Jul 15; 33(3):894-903. PubMed ID: 32356243
    [Abstract] [Full Text] [Related]

  • 17. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Akiyama T, Sugaya J, Nakatani F, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2022 Jan 15; 35(1):384-391. PubMed ID: 34665443
    [Abstract] [Full Text] [Related]

  • 18. Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.
    Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Ono T, Akiyama T, Hirabayashi K, Ozawa I, Nakagawa R, Kikuta K, Kondo T.
    Hum Cell; 2022 Jul 15; 35(4):1279-1289. PubMed ID: 35637403
    [Abstract] [Full Text] [Related]

  • 19. Establishment and characterization of a novel patient-derived cell line of dedifferentiated liposarcoma, NCC-DDLPS6-C1.
    Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Nakagawa R, Kamio S, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2022 Jul 15; 35(4):1270-1278. PubMed ID: 35604485
    [Abstract] [Full Text] [Related]

  • 20. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
    Yoshimatsu Y, Noguchi R, Osaki J, Sin Y, Tsuchiya R, Ono T, Akiyama T, Adachi Y, Tanzawa Y, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2024 Jan 15; 37(1):337-344. PubMed ID: 37907774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.